Insights

Gathering insights about SLS…

Similar companies to SLS

SLS Tech Stack

SLS uses 3 technology products and services including Google Fonts API, yepnope.js, ZURB Foundation, and more. Explore SLS's tech stack below.

Google Fonts API
Font Scripts
yepnope.js
Javascript Frameworks
ZURB Foundation
UI Frameworks

Media & News

SELLAS Life Sciences Group Sees Unusually Large Options Volume (NASDAQ:SLS)
SELLAS Life Sciences Group, Inc. (NASDAQ: SLS - Get Free Report) saw unusually large options trading on Friday. Traders bought 149,934 call options on the company. This is an increase of approximately 829% compared to the average volume of 16,138 call options. Analyst Upgrades and Downgrades Separately, Weiss Ratings restated a "sell (d-)" rating on shares
Jan 03, 2026 | www.defenseworld.net
SELLAS Life Sciences Group (NASDAQ:SLS) Shares Gap Up – What’s Next?
SELLAS Life Sciences Group, Inc. (NASDAQ: SLS - Get Free Report)'s share price gapped up before the market opened on Wednesday. The stock had previously closed at $3.31, but opened at $3.46. SELLAS Life Sciences Group shares last traded at $3.5950, with a volume of 11,566,353 shares trading hands. Wall Street Analysts Forecast Growth Separately,
Jan 02, 2026 | www.defenseworld.net
SELLAS Life Sciences Stock Is Surging Higher: What's Going On?
SELLAS Life Sciences Group climbs higher after a premarket drop, reversing course as investors seem to react to new trial‑related updates.
Dec 29, 2025 | www.benzinga.com
SELLAS Life Sciences Provides Update on Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML)
NEW YORK, Dec. 29, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS'' or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today provided an update on the ongoing Phase 3 REGAL trial evaluating GPS as a potential maintenance therapy in patients with AML after second complete remission (CR2).
Dec 29, 2025 | www.globenewswire.com
Precision's Payoff: Targeted Therapies Drive $131B Solid Tumor Market Surge
VANCOUVER, British Columbia, Dec. 24, 2025 (GLOBE NEWSWIRE) -- Equity Insider News Commentary - The U. S. oncology market is projected to surge from $81 billion in 2025 to $212 billion by 2034[1], driven by a fundamental shift in how physicians combat cancer's most resistant forms.
Dec 24, 2025 | www.globenewswire.com
SELLAS Life Sciences Presents Positive Phase 2 Data of SLS009 in Combination with AZA/VEN in Relapsed/Refractory AML-MR at ASH 2025
NEW YORK, Dec. 07, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS'' or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced that clinical data from its ongoing Phase 2 study of SLS009, a highly selective CDK9 inhibitor, in combination with azacitidine (AZA) and venetoclax (VEN) for the treatment of patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) with myelodysplastic syndrome-related changes (AML-MR) after prior VEN-based treatment were presented today at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition, being held December 6 – 9, 2025, in Orlando, Florida.
Dec 07, 2025 | www.globenewswire.com
Blood Cancer Therapeutics Reach Critical Commercial and Clinical Inflection Points
/PRNewswire/ -- Triple-therapy immunotherapy approaches are demonstrating complete leukemia elimination in preclinical models by reprogramming how cancer cells
Dec 04, 2025 | www.prnewswire.com

SLS's Email Address Formats

SLS uses at least 1 format(s):

SLS Email Formats	Example	Percentage
First.Last@sls.net	John.Doe@sls.net	96%
FirstLast@sls.net	JohnDoe@sls.net	2%
F.Last@sls.net	J.Doe@sls.net	2%

Frequently Asked Questions

What is SLS's phone number?

You can contact SLS's main corporate office by phone at

+1-720-241-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is SLS's stock symbol?

SLS is a publicly traded company; the company's stock symbol is SLS.

What is SLS's official website and social media links?

SLS's official website is sls.net and has social profiles on LinkedIn.

How much revenue does SLS generate?

As of December 2025, SLS's annual revenue is estimated to be $656M.

What is SLS's NAICS code?

SLS's NAICS code is 52 - Finance and Insurance.

How many employees does SLS have currently?

As of December 2025, SLS has approximately 1K employees across 5 continents, including North AmericaAsiaEurope. Key team members include Ceo Retired From Sls: J. B.Vice President And Counsel: C. P.Vp Loan Servicing: R. M.. Explore SLS's employee directory with LeadIQ.

What industry does SLS belong to?

SLS operates in the Financial Services industry.

What technology does SLS use?

SLS's tech stack includes Google Fonts APIyepnope.jsZURB Foundation.

What is SLS's email format?

SLS's email format typically follows the pattern of First.Last@sls.net. Find more SLS email formats with LeadIQ.

When was SLS founded?

SLS was founded in 2003.

SLS

Q: What is SLS's official website and social media links?

SLS's official website is sls.net. SLS has social profiles on LinkedIn.

Q: How many employees does SLS have currently?

SLS has approximately 1K employees.

Q: What technology does SLS use?

SLS's tech stack includes ZURB Foundation, Google Fonts API, yepnope.js.

Financial ServicesColorado, United States1001-5000 Employees

Specialized Loan Servicing (SLS) is one of the highest-rated mortgage subservicers in the US, with a proven record of delivering superior portfolio performance and exceptional borrower care throughout the lifecycle of each loan. 

Specialized Loan Servicing LLC: NMLS 2168